Dachaigh › Hemophilia
Sgrùdaidhean clionaigeach Hemophilia a’ fastadh anns na SA
Tha 29 sgrùdaidhean airson Hemophilia a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Indianapolis, IN9 sgrùdaidhean
- Los Angeles, CA7 sgrùdaidhean
- Seattle, WA6 sgrùdaidhean
- Cedar Rapids, IA6 sgrùdaidhean
- Philadelphia, PA5 sgrùdaidhean
- Little Rock, AR5 sgrùdaidhean
- Tampa, FL4 sgrùdaidhean
- Sacramento, CA4 sgrùdaidhean
- Dallas, TX4 sgrùdaidhean
- Atlanta, GA4 sgrùdaidhean
- Greenville, NC4 sgrùdaidhean
- Orange, CA4 sgrùdaidhean
- San Francisco, CA3 sgrùdaidhean
- Cincinnati, OH3 sgrùdaidhean
- Detroit, MI3 sgrùdaidhean
- Kansas City, MO3 sgrùdaidhean
- Boston, MA3 sgrùdaidhean
- Chicago, IL3 sgrùdaidhean
- St. Louis, MO3 sgrùdaidhean
- Harrisburg, PA3 sgrùdaidhean
- Aurora, CO3 sgrùdaidhean
- San Antonio, TX3 sgrùdaidhean
Le stàit
- Arkansas5 sgrùdaidhean
- California14 sgrùdaidhean
- Colorado3 sgrùdaidhean
- Florida6 sgrùdaidhean
- Georgia4 sgrùdaidhean
- Illinois4 sgrùdaidhean
- Indiana9 sgrùdaidhean
- Iowa6 sgrùdaidhean
- Massachusetts3 sgrùdaidhean
- Michigan5 sgrùdaidhean
- Missouri5 sgrùdaidhean
- New York4 sgrùdaidhean
- North Carolina6 sgrùdaidhean
- Ohio5 sgrùdaidhean
- Pennsylvania6 sgrùdaidhean
- Texas8 sgrùdaidhean
- Washington6 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)
A’ fastadhSgrùdadh amharc
Aoisean 30 gu 50 · Fir · Air ùrachadh 5 Dàmh 2026 · NCT07582276Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Dàmh 2026 · NCT05568719TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
A’ fastadhSgrùdadh amharc
6 Months · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07692217A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
A’ fastadhÌre 3
Aoisean 1 gu 17 · Fir · Air ùrachadh 23 Sult 2026 · NCT05611801Treatment of Hemophilia A Patients With FVIII Inhibitors
A’ fastadhSgrùdadh amharc
Gach aois · Fir · Air ùrachadh 23 Sult 2026 · NCT04023019A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07416526A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
A’ fastadhÌre 4
Aoisean 12 agus nas sine · Fir · Air ùrachadh 23 Sult 2026 · NCT06145373A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 64 · Fir · Air ùrachadh 18 Sult 2026 · NCT07220564A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 11 Sult 2026 · NCT07226206A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
A’ fastadhÌre 1/2
Aoisean 2 gu 59 · Fir · Air ùrachadh 11 Sult 2026 · NCT05987449A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07416604Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 0 gu 20 · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT04278404SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
A’ fastadhÌre 3
Aoisean 6 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT04563520ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
A’ fastadhÌre 3
Aoisean 1 gu 11 · Fir · Air ùrachadh 17 Lùna 2026 · NCT07285460A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT06349473Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
A’ fastadhSgrùdadh amharc
Aoisean 6 gu 19 · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05022459Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
A’ fastadhÌre 3
Aoisean 1 gu 74 · Fir · Air ùrachadh 1 Iuch 2026 · NCT05145127A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
A’ fastadhÌre 1
Aoisean 12 gu 74 · Fir · Air ùrachadh 3 Ògmh 2026 · NCT06703606Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 2 Ògmh 2026 · NCT03695978Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
A’ fastadhÌre 4
Aoisean 12 agus nas sine · Fir · Air ùrachadh 12 Cèit 2026 · NCT05935358Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
A’ fastadhÌre 4
Aoisean 12 agus nas sine · Banairean · Air ùrachadh 12 Cèit 2026 · NCT05936580ATHNdataset Registry
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 21 Gibl 2026 · NCT06820515Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
A’ fastadhÌre 1
Aoisean 0 gu 90 · Gach gnè · Air ùrachadh 3 Gibl 2026 · NCT05500807Hemophilia A Research Program
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 17 Gearr 2026 · NCT07414511Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.